Autoimmune Diseases News

Autoimmune Diseases	Welcome, Profile Billing Logout

«1 2...9 10 11 12 131415 16 17 18 19...156 157 »

||||||||||  branebrutinib (BMS-986195) / BMS
Trial completion, Enrollment change:  Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects (clinicaltrials.gov) -  Aug 31, 2017
P1, N=439, Completed,  Sponsor: Bristol-Myers Squibb
Active, not recruiting --> Completed | N=118 --> 439

|||||||||| Trial completion: Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis (clinicaltrials.gov) - Aug 30, 2017
P=N/A, N=267, Completed, Sponsor: Mount Sinai Rehabilitation Hospital
Active, not recruiting --> Completed | N=118 --> 439 Active, not recruiting --> Completed

|||||||||| Trial completion, Trial primary completion date: valid-PVLT: Paris Visual Learning Test: a New French Task for Assess Visual Learning and Memory to Multiple Sclerosis Patients (clinicaltrials.gov) - Aug 30, 2017
P=N/A, N=50, Completed, Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017

|||||||||| Trial completion: Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis (clinicaltrials.gov) - Aug 30, 2017
P=N/A, N=125, Completed, Sponsor: Mayo Clinic
Recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017 Recruiting --> Completed

|||||||||| Enrollment change: CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study (clinicaltrials.gov) - Aug 30, 2017
P=N/A, N=40, Completed, Sponsor: George Washington University
Recruiting --> Completed N=300 --> 40

||||||||||  Tepezza (teprotumumab-trbw) / Roche, Amgen
Trial completion:  Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease (clinicaltrials.gov) -  Aug 30, 2017
P2, N=88, Completed,  Sponsor: Horizon Pharma USA, Inc.
N=300 --> 40 Active, not recruiting --> Completed

|||||||||| Phase classification: Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis (clinicaltrials.gov) - Aug 30, 2017
P, N=30, Completed, Sponsor: medac GmbH
Active, not recruiting --> Completed Phase classification: P=N/A --> P

||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Trial completion, P1 data, Enrollment change, Trial primary completion date, MRI:  A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients (clinicaltrials.gov) -  Aug 30, 2017
P1, N=8, Completed,  Sponsor: Johns Hopkins University
Phase classification: P=N/A --> P Recruiting --> Completed | N=12 --> 8 | Trial primary completion date: Dec 2017 --> Aug 2017

|||||||||| Trial initiation date, Trial primary completion date: Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes (clinicaltrials.gov) - Aug 30, 2017
P2, N=45, Not yet recruiting, Sponsor: Institut de Recherches Cliniques de Montreal
Recruiting --> Completed | N=12 --> 8 | Trial primary completion date: Dec 2017 --> Aug 2017 Initiation date: Jan 2017 --> Nov 2017 | Trial primary completion date: Jul 2017 --> Nov 2018

||||||||||  Betaseron (IFN-β-1b) / Bayer
Patient reported outcomes:  PROmyBETAapp: Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study (clinicaltrials.gov) -  Aug 29, 2017
P=N/A, N=40, Not yet recruiting,  Sponsor: Bayer
Initiation date: Jan 2017 --> Nov 2017 | Trial primary completion date: Jul 2017 --> Nov 2018 Trial primary completion date: Jan 2018 --> May 2018

|||||||||| Enrollment change, Trial termination, Trial primary completion date: Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy (clinicaltrials.gov) - Aug 28, 2017
P=N/A, N=28, Terminated, Sponsor: VU University Medical Center
N=60 --> 28 | Recruiting --> Terminated | Trial primary completion date: Jan 2018 --> Jun 2017; All Parkinson's disease patients have finished training. The MS and ECT groups have not finished as these groups had trouble including 20 patients.

|||||||||| Enrollment closed, Trial initiation date, Trial primary completion date: Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis (clinicaltrials.gov) - Aug 28, 2017
P=N/A, N=30, Active, not recruiting, Sponsor: Oregon Health and Science University
The MS and ECT groups have not finished as these groups had trouble including 20 patients. Recruiting --> Active, not recruiting | Initiation date: Oct 2016 --> Feb 2017 | Trial primary completion date: Jun 2017 --> Jan 2018

||||||||||  DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk
Trial completion:  Post Marketing Surveillance (PMS) Study of Ryzodeg (clinicaltrials.gov) -  Aug 28, 2017
P=N/A, N=1029, Completed,  Sponsor: Novo Nordisk A/S
Recruiting --> Active, not recruiting | Initiation date: Oct 2016 --> Feb 2017 | Trial primary completion date: Jun 2017 --> Jan 2018 Active, not recruiting --> Completed

||||||||||  AMG 131 / Coherus Biosci
Trial completion, Trial primary completion date, Monotherapy:  This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Versus Placebo 1 Tablet PO QD in Subjects With Treatment-na (clinicaltrials.gov) -  Aug 28, 2017
P2, N=228, Completed,  Sponsor: InteKrin Therapeutics, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2016

|||||||||| Trial completion: Check It! 2.0: Positive Psychology Intervention for Adolescents With Type 1 Diabetes (clinicaltrials.gov) - Aug 25, 2017
P=N/A, N=48, Completed, Sponsor: Vanderbilt University
Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2016 Active, not recruiting --> Completed

||||||||||  tregalizumab (BT-061) - ADMA Biologics, T / Balance Therapeutics
Trial primary completion date, Combination therapy:  Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis (clinicaltrials.gov) -  Aug 24, 2017
P2b, N=321, Terminated,  Sponsor: Biotest
Active, not recruiting --> Completed Trial primary completion date: Feb 2015 --> Jul 2015

|||||||||| Trial primary completion date: AIRSEP: Fatigue and Inspiratory Muscles Training in Patients With Multiple Sclerosis (clinicaltrials.gov) - Aug 24, 2017
P=N/A, N=60, Recruiting, Sponsor: Lille Catholic University
Trial primary completion date: Feb 2015 --> Jul 2015 Trial primary completion date: Aug 2017 --> Aug 2018

|||||||||| Enrollment open: GASTRO-SGS: Evaluation of the Prevalence of Functional Digestive Disorders During Primary Sjögren Gougerot Syndrome (clinicaltrials.gov) - Aug 24, 2017
P=N/A, N=151, Recruiting, Sponsor: University Hospital, Limoges
Trial primary completion date: Aug 2017 --> Aug 2018 Not yet recruiting --> Recruiting

|||||||||| Trial completion, Trial primary completion date: Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica (clinicaltrials.gov) - Aug 23, 2017
P=N/A, N=142, Completed, Sponsor: Lahey Clinic
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Aug 2013

|||||||||| Enrollment closed, Trial primary completion date: NUTRISEP: Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis (clinicaltrials.gov) - Aug 23, 2017
P=N/A, N=360, Active, not recruiting, Sponsor: Lille Catholic University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Aug 2013 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Jun 2017

|||||||||| Trial completion, Trial primary completion date: A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis (MS) (clinicaltrials.gov) - Aug 23, 2017
P=N/A, N=54, Completed, Sponsor: Johns Hopkins University
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Jun 2017 Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jun 2017

||||||||||  Diamyd (rhGAD65/alum) / Diamyd Medical
Trial completion, Combination therapy:  DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen (clinicaltrials.gov) -  Aug 23, 2017
P2, N=60, Completed,  Sponsor: Johnny Ludvigsson
Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jun 2017 Active, not recruiting --> Completed

|||||||||| Trial completion, Phase classification, Surgery: Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand (clinicaltrials.gov) - Aug 22, 2017
P=N/A, N=170, Completed, Sponsor: University of Michigan
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P4 --> PN/A

|||||||||| Trial completion, Enrollment change, Trial primary completion date, HEOR: Effect of Active-Passive Trainer Cycling on Multiple Sclerosis (clinicaltrials.gov) - Aug 22, 2017
P=N/A, N=24, Completed, Sponsor: NHS Greater Glasgow and Clyde
Active, not recruiting --> Completed | Phase classification: P4 --> PN/A Not yet recruiting --> Completed | N=30 --> 24 | Trial primary completion date: May 2017 --> Jul 2017

|||||||||| Enrollment closed, Adherence: APRim: Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis (clinicaltrials.gov) - Aug 21, 2017
P=N/A, N=560, Active, not recruiting, Sponsor: Nordic Pharma SAS
Not yet recruiting --> Completed | N=30 --> 24 | Trial primary completion date: May 2017 --> Jul 2017 Recruiting --> Active, not recruiting

|||||||||| Trial completion: A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus (clinicaltrials.gov) - Aug 21, 2017
P1, N=47, Completed, Sponsor: Novo Nordisk A/S
Recruiting --> Active, not recruiting Active, not recruiting --> Completed

|||||||||| Trial primary completion date: Resistance Exercise in Rheumatic Disease (clinicaltrials.gov) - Aug 18, 2017
P=N/A, N=10, Recruiting, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed Trial primary completion date: Jul 2016 --> Jul 2018

||||||||||  dalfampridine / Generic mfg.
Trial primary completion date:  Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch) (clinicaltrials.gov) -  Aug 18, 2017
P2, N=25, Active, not recruiting,  Sponsor: Johns Hopkins University
Trial primary completion date: Jul 2016 --> Jul 2018 Trial primary completion date: Nov 2016 --> May 2017

|||||||||| Trial suspension, Trial primary completion date: PRESSRA: The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis (clinicaltrials.gov) - Aug 18, 2017
P=N/A, N=50, Suspended, Sponsor: Johns Hopkins University
Trial primary completion date: Nov 2016 --> May 2017 Recruiting --> Suspended | Trial primary completion date: Jul 2016 --> Dec 2017

|||||||||| Trial completion, Trial primary completion date: PHYSACTINMS: Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes (clinicaltrials.gov) - Aug 18, 2017
P=N/A, N=18, Completed, Sponsor: Kessler Foundation
Recruiting --> Suspended | Trial primary completion date: Jul 2016 --> Dec 2017 Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Jun 2016

||||||||||  Nplate (romiplostim) / Amgen, Kyowa Kirin
Trial completion, Trial primary completion date:  Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) (clinicaltrials.gov) -  Aug 18, 2017
P3, N=203, Completed,  Sponsor: Kyowa Hakko Kirin China Pharmaceutical Co.,LTD.
Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Jun 2016 Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Feb 2017

||||||||||  andecaliximab (GS-5745) / Gilead
Trial termination, Trial primary completion date:  RA POC: Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis (clinicaltrials.gov) -  Aug 17, 2017
P2, N=15, Terminated,  Sponsor: Gilead Sciences
Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Feb 2017 Active, not recruiting --> Terminated | Trial primary completion date: Apr 2018 --> Jul 2017; Study was terminated by sponsor and decision was not due to any safety signals.

||||||||||  Plegridy (PEG-interferon β-1a) / Biogen
Phase classification:  Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY (clinicaltrials.gov) -  Aug 14, 2017
P4, N=32, Terminated,  Sponsor: New York University School of Medicine
Active, not recruiting --> Terminated | Trial primary completion date: Apr 2018 --> Jul 2017; Study was terminated by sponsor and decision was not due to any safety signals. Phase classification: P=N/A --> P4

||||||||||  Metoject (methotrexate autopen) / Medac
Enrollment closed, Compliance:  Self-i: Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe (clinicaltrials.gov) -  Aug 14, 2017
P3, N=278, Active, not recruiting,  Sponsor: GECEM
Phase classification: P=N/A --> P4 Recruiting --> Active, not recruiting

|||||||||| Enrollment open: ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis) (clinicaltrials.gov) - Aug 14, 2017
P=N/A, N=80, Recruiting, Sponsor: Göteborg University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting

|||||||||| Trial completion, Trial primary completion date, IO biomarker: Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) - Aug 14, 2017
P=N/A, N=629, Completed, Sponsor: Assistance Publique - H
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jul 2014

|||||||||| Enrollment open: The Artificial Pancreas in Very Young Children With T1D - Pilot (KidsAP01) (clinicaltrials.gov) - Aug 14, 2017
P=N/A, N=30, Recruiting, Sponsor: University of Cambridge
Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jul 2014 Not yet recruiting --> Recruiting

|||||||||| Enrollment change, Trial primary completion date: Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes (clinicaltrials.gov) - Aug 11, 2017
P2, N=37, Recruiting, Sponsor: Institut de Recherches Cliniques de Montreal
Not yet recruiting --> Recruiting N=30 --> 37 | Trial primary completion date: Jun 2018 --> Sep 2018

||||||||||  bortezomib / Generic mfg.
Trial completion, Enrollment change:  Pilot Study of Velcade® in IgA Nephropathy (clinicaltrials.gov) -  Aug 10, 2017
P4, N=11, Completed,  Sponsor: The Rogosin Institute
N=30 --> 37 | Trial primary completion date: Jun 2018 --> Sep 2018 Recruiting --> Completed | N=15 --> 11

|||||||||| Trial completion, Enrollment change: GOCol: Graves' Orbitopathy and Hypercholesterolemia (clinicaltrials.gov) - Aug 10, 2017
P=N/A, N=250, Completed, Sponsor: University of Pisa
Recruiting --> Completed | N=15 --> 11 Recruiting --> Completed | N=200 --> 250

|||||||||| Enrollment change, Trial withdrawal: DiaCon Dual-Hormone Closed-Loop Glucose Control (clinicaltrials.gov) - Aug 9, 2017
P2/3, N=0, Withdrawn, Sponsor: Hvidovre University Hospital
Recruiting --> Completed | N=200 --> 250 N=13 --> 0 | Not yet recruiting --> Withdrawn

||||||||||  Suglat (ipragliflozin) / EMD Serono, Kotobuki, Astellas
Trial primary completion date, Combination therapy:  A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus (clinicaltrials.gov) -  Aug 9, 2017
P3, N=175, Active, not recruiting,  Sponsor: Astellas Pharma Inc
N=13 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Feb 2018 --> Jul 2017

||||||||||  HDV insulin lispro (HDV-L) / Diasome
Enrollment closed, Combination therapy:  Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1) (clinicaltrials.gov) -  Aug 9, 2017
P2b, N=157, Active, not recruiting,  Sponsor: Diasome Pharmaceuticals
Trial primary completion date: Feb 2018 --> Jul 2017 Recruiting --> Active, not recruiting

||||||||||  Orencia (abatacept) / BMS
Trial primary completion date:  Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) (clinicaltrials.gov) -  Aug 8, 2017
P=N/A, N=20000, Active, not recruiting,  Sponsor: Bristol-Myers Squibb
Recruiting --> Active, not recruiting Trial primary completion date: Aug 2017 --> Sep 2019

|||||||||| Enrollment change, Trial withdrawal, Trial primary completion date: Examining the Immunological Process of Autoimmune Patients (clinicaltrials.gov) - Aug 8, 2017
P=N/A, N=0, Withdrawn, Sponsor: University of Florida
Trial primary completion date: Aug 2017 --> Sep 2019 N=200 --> 0 | Suspended --> Withdrawn | Trial primary completion date: Jul 2017 --> Aug 2016

|||||||||| Trial termination, Trial primary completion date: MCP: Ascension (clinicaltrials.gov) - Aug 8, 2017
P=N/A, N=96, Terminated, Sponsor: Integra LifeSciences Corporation
N=200 --> 0 | Suspended --> Withdrawn | Trial primary completion date: Jul 2017 --> Aug 2016 Active, not recruiting --> Terminated | Trial primary completion date: Jan 2020 --> Jan 2015; Business Priorities

|||||||||| Enrollment closed: Efficacy of Coenzyme q10 in Pediatrics With Type 1 Diabetes Mellitus (clinicaltrials.gov) - Aug 8, 2017
P2, N=49, Active, not recruiting, Sponsor: Ain Shams University
Active, not recruiting --> Terminated | Trial primary completion date: Jan 2020 --> Jan 2015; Business Priorities Recruiting --> Active, not recruiting | N=40 --> 49 | Trial primary completion date: Aug 2017 --> Nov 2017 | Recruiting --> Active, not recruiting

||||||||||  opigolix (ASP1707) / Astellas
Enrollment closed:  A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate (clinicaltrials.gov) -  Aug 7, 2017
P2a, N=72, Active, not recruiting,  Sponsor: Astellas Pharma Inc
Recruiting --> Active, not recruiting | N=40 --> 49 | Trial primary completion date: Aug 2017 --> Nov 2017 | Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting

||||||||||  aspirin / Generic mfg.
Trial completion, Enrollment change:  Aspirin Resistance in Systemic Lupus Erythematosus (SLE) (clinicaltrials.gov) -  Aug 7, 2017
P1, N=70, Completed,  Sponsor: Vanderbilt University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=120 --> 70

|||||||||| Trial completion, Trial primary completion date: Web-based Support During Pregnancy and Early Motherhood in Women With Type 1 Diabetes (MODIAB-web) (clinicaltrials.gov) - Aug 7, 2017
P=N/A, N=174, Completed, Sponsor: G
Active, not recruiting --> Completed | N=120 --> 70 Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Mar 2016



	Diseases Companies Products Productz Mechanisms of Action Sites